Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» treatment-resistant breast cancer
treatment-resistant breast cancer
With new name, new CEO, Cascadian now rolls out a new pivotal plan for lead cancer drug
Endpoints
Wed, 12/7/16 - 10:16 am
Oncothyreon
Cascadian
tucatinib
ONT-380
treatment-resistant breast cancer
breast cancer